» Articles » PMID: 37910283

In Vivo Intracerebral Administration of α-Ketoisocaproic Acid to Neonate Rats Disrupts Brain Redox Homeostasis and Promotes Neuronal Death, Glial Reactivity, and Myelination Injury

Abstract

Maple syrup urine disease (MSUD) is caused by severe deficiency of branched-chain α-keto acid dehydrogenase complex activity, resulting in tissue accumulation of branched-chain α-keto acids and amino acids, particularly α-ketoisocaproic acid (KIC) and leucine. Affected patients regularly manifest with acute episodes of encephalopathy including seizures, coma, and potentially fatal brain edema during the newborn period. The present work investigated the ex vivo effects of a single intracerebroventricular injection of KIC to neonate rats on redox homeostasis and neurochemical markers of neuronal viability (neuronal nuclear protein (NeuN)), astrogliosis (glial fibrillary acidic protein (GFAP)), and myelination (myelin basic protein (MBP) and 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNPase)) in the cerebral cortex and striatum. KIC significantly disturbed redox homeostasis in these brain structures 6 h after injection, as observed by increased 2',7'-dichlorofluorescein oxidation (reactive oxygen species generation), malondialdehyde levels (lipid oxidative damage), and carbonyl formation (protein oxidative damage), besides impairing the antioxidant defenses (diminished levels of reduced glutathione and altered glutathione peroxidase, glutathione reductase, and superoxide dismutase activities) in both cerebral structures. Noteworthy, the antioxidants N-acetylcysteine and melatonin attenuated or normalized most of the KIC-induced effects on redox homeostasis. Furthermore, a reduction of NeuN, MBP, and CNPase, and an increase of GFAP levels were observed at postnatal day 15, suggesting neuronal loss, myelination injury, and astrocyte reactivity, respectively. Our data indicate that disruption of redox homeostasis, associated with neural damage caused by acute intracerebral accumulation of KIC in the neonatal period may contribute to the neuropathology characteristic of MSUD patients.

Citing Articles

The role of NLRP3 inflammasome-mediated pyroptosis in astrocytes during hyperoxia-induced brain injury.

Liu Q, Tan Y, Zhang Z, Tang W, Han L, Peng K Inflamm Res. 2025; 74(1):25.

PMID: 39862240 DOI: 10.1007/s00011-024-01984-4.


Dysfunctional BCAA degradation triggers neuronal damage through disrupted AMPK-mitochondrial axis due to enhanced PP2Ac interaction.

Wu S, Chen Y, Su S, Fang P, Liu R, Tsai H Commun Biol. 2025; 8(1):105.

PMID: 39838082 PMC: 11751115. DOI: 10.1038/s42003-025-07457-6.


Primary Roles of Branched Chain Amino Acids (BCAAs) and Their Metabolism in Physiology and Metabolic Disorders.

Bo T, Fujii J Molecules. 2025; 30(1.

PMID: 39795113 PMC: 11721030. DOI: 10.3390/molecules30010056.

References
1.
Strauss K, Carson V, Soltys K, Young M, Bowser L, Puffenberger E . Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes. Mol Genet Metab. 2020; 129(3):193-206. DOI: 10.1016/j.ymgme.2020.01.006. View

2.
Chen T, Lu D, Xu F, Ji W, Zhan X, Gao X . Newborn screening of maple syrup urine disease and the effect of early diagnosis. Clin Chim Acta. 2023; 548:117483. DOI: 10.1016/j.cca.2023.117483. View

3.
Li L, Mao X, Yang N, Ji T, Wang S, Ma Y . Identification of gene mutations in six Chinese patients with maple syrup urine disease. Front Genet. 2023; 14:1132364. PMC: 10001893. DOI: 10.3389/fgene.2023.1132364. View

4.
Cheng A, Han L, Feng Y, Li H, Yao R, Wang D . MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases. Diagn Interv Radiol. 2017; 23(5):398-402. PMC: 5602367. DOI: 10.5152/dir.2017.16466. View

5.
Kathait A, Puac P, Castillo M . Imaging Findings in Maple Syrup Urine Disease: A Case Report. J Pediatr Neurosci. 2018; 13(1):103-105. PMC: 5982476. DOI: 10.4103/JPN.JPN_38_17. View